Mersana Therapeutics Inc (NAS:MRSN)
$ 2.37 0.07 (3.04%) Market Cap: 292.77 Mil Enterprise Value: 160.46 Mil PE Ratio: 0 PB Ratio: 237.00 GF Score: 29/100

Q4 2021 Mersana Therapeutics Inc Earnings Call Transcript

Feb 28, 2022 / 01:00PM GMT
Release Date Price: $4.39 (+7.33%)
Operator

Good morning, and welcome to Mersana Therapeutics' Fourth Quarter and Year-End 2021 Conference Call and Webcast. (Operator Instructions).

I would now like to turn the call over to James Salierno, Associate Director, Investor Relations. Please proceed.

James Salierno
Mersana Therapeutics, Inc. - Associate Director of IR

Good morning. Welcome to Mersana's Fourth Quarter and Year-End 2021 Conference Call. Earlier today, we issued a press release reviewing our fourth quarter and full year financial results and business updates, which will be covered on this call. A replay of today's call will also be available on the Investors and Media section of our website. After our prepared remarks, we will open up the call for Q&A.

Before we begin, I'd like to mention that our call will contain forward-looking statements within the meaning of federal securities laws, including with respect to the company's business strategy and the design, progression and timing of its clinical trials or preclinical studies and the release of data from those studies

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot